Temazepam is a benzodiazepine prescribed for insomnia, and it’s only FDA-approved for short-term use of 7 to 10 days. Its label states that safety and effectiveness beyond two weeks have not been established. Yet many people end up taking it far longer, and the consequences of extended use touch nearly every aspect of brain and body function, from memory and sleep quality to fall risk and potential links to dementia.
How Tolerance and Dependence Develop
Temazepam works by amplifying the effects of GABA, a brain chemical that calms nerve activity. It increases the flow of chloride ions into nerve cells, making them less excitable. This is what produces the sedating, sleep-promoting effect.
The problem is that your brain adapts. With repeated exposure, neurons compensate for the constant suppression by becoming more excitable on their own. This is tolerance: you need a higher dose to get the same sleep benefit. Tolerance can develop within weeks of regular use, and once your nervous system has recalibrated around the presence of the drug, you’ve become physically dependent. At that point, stopping abruptly leaves the brain in a hyperexcitable state, which is what drives withdrawal symptoms.
Cognitive Impairment That Outlasts the Drug
One of the most concerning long-term effects is persistent cognitive decline. A study comparing older adults who used temazepam (or similar sleep medications) long-term against those who never took them found that users had measurably slower reaction times. That gap didn’t close quickly after stopping. Even six months after withdrawal, former users still showed impaired attention and psychomotor function compared to people who had never used these drugs. Their vigilance (ability to sustain focus) did recover, but the slower processing speed did not fully return to normal within the study period.
This isn’t just about feeling foggy. Slower reaction times affect driving, balance, and the ability to respond to unexpected situations, all of which carry real safety consequences, especially for older adults.
Changes to Sleep Quality
Temazepam may help you fall asleep, but the sleep it produces isn’t identical to natural sleep. Research using high-density brain monitoring found that temazepam significantly reduced slow-wave activity, the deep, restorative phase of sleep that’s critical for memory consolidation and physical recovery. The drug decreased both the frequency and the size of these deep brain waves, with the most pronounced effects in the frontal brain regions and during the later portions of the night.
REM sleep (the dreaming stage) appears largely unaffected by a single dose. However, the suppression of deep sleep means that even though you’re unconscious for longer, the quality of that sleep is diminished. Over months or years of use, this degraded sleep architecture may contribute to the cognitive problems described above and can leave you feeling unrefreshed despite a full night in bed.
Withdrawal Symptoms and Rebound Insomnia
Stopping temazepam after long-term use triggers a predictable set of withdrawal symptoms. The typical pattern includes sleep disturbance, irritability, heightened anxiety, panic attacks, hand tremor, sweating, difficulty concentrating, nausea, palpitations, headache, and muscle pain and stiffness. Some people also experience perceptual changes, such as increased sensitivity to light or sound. In rare cases involving high doses, seizures and psychotic reactions have been reported.
Withdrawal generally follows one of three patterns. The most common is short-lived rebound anxiety and insomnia appearing within one to four days after the last dose. The second is a full withdrawal syndrome lasting roughly 10 to 14 days. The third is a return of the original anxiety or insomnia symptoms that persists indefinitely until addressed with another form of treatment. Notably, rebound insomnia with temazepam at standard doses (15 or 30 mg) tends to be milder compared to shorter-acting benzodiazepines, though it still occurs.
Because of these risks, doctors typically taper the dose gradually rather than stopping all at once. A slow taper gives the nervous system time to readjust and reduces the severity of withdrawal.
Increased Risk of Dementia
A meta-analysis published in the Journal of Clinical Neurology pooled data from multiple observational studies and found that long-term benzodiazepine users had a 51% higher risk of developing dementia compared to non-users. The risk was greatest for people who used benzodiazepines with longer half-lives (over 20 hours) and for durations exceeding three years. Temazepam, classified as intermediate-acting with a half-life of 12 to 24 hours, falls in the middle of the risk spectrum.
The researchers noted that long-term use is associated with an accumulation of generalized cognitive deficits that may contribute to this elevated dementia risk. Whether the drugs directly cause dementia or whether the relationship is partly explained by other factors (such as the underlying sleep disorders or anxiety that led to prescribing) remains debated. But the statistical association is consistent and significant enough to be taken seriously, particularly for people over 65.
Fall and Fracture Risk in Older Adults
Benzodiazepines are one of the most well-documented risk factors for falls in older adults. A systematic review and meta-analysis found that short-term benzodiazepine use increased hip fracture risk by 140%, medium-term use by 53%, and long-term use by 20%. The declining percentage over time likely reflects a survivorship effect: people who tolerate the drug without falling early on are less susceptible, and those most at risk tend to stop or experience fractures sooner.
Still, a 20% elevated fracture risk that persists with long-term use is significant. Hip fractures in older adults carry serious consequences, including prolonged hospitalization, loss of independence, and increased mortality in the year following the injury. The sedation, muscle relaxation, and slowed reaction times caused by temazepam all contribute to unsteady gait and impaired balance.
Emotional Blunting and Daytime Effects
Beyond the measurable cognitive and physical effects, many long-term users report a flattening of emotional range. Because temazepam dampens overall nervous system activity, it can reduce not just anxiety but also motivation, emotional responsiveness, and the ability to feel engaged during the day. This isn’t always dramatic enough to be recognized as a side effect. It often creeps in gradually, and people may attribute it to aging, depression, or stress rather than the medication itself.
Daytime drowsiness is another persistent issue. Temazepam’s half-life means the drug is still partially active the morning after a dose, and with long-term use, the cumulative effect can leave you in a state of low-grade sedation throughout the day. This compounds the reaction-time impairment and fall risk already described.
Why Short-Term Becomes Long-Term
The cycle is predictable. Temazepam works well for sleep in the first week or two. As tolerance builds, the original dose becomes less effective. Meanwhile, the brain has adapted to the drug’s presence, so stopping brings rebound insomnia that feels worse than the original problem. This creates a trap: the drug seems necessary because stopping it makes sleep worse, even though continued use is degrading sleep quality and cognitive function in ways that aren’t immediately obvious. Recognizing this cycle is the first step toward working with a provider on a safe tapering plan and transitioning to non-drug approaches like cognitive behavioral therapy for insomnia, which has comparable effectiveness without the long-term risks.